Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Post Graduate and Executive Diploma in - The Pharma Times | Pharma & Health Care News Portal
Categories: Regulatory Norms

Post Graduate and Executive Diploma in

 i) Good Manufacturing Practices
ii) Quality Assurance and Quality Control
iii) Regulatory Affairs &
iv) Clinical Research (E/distance mode)

For further details on GMP programmes VIEW , QA&QC programmesVIEW , Regulatory Affairs programmesVIEW and Clinical Research programmesVIEW or for free PDF copy of the Prospectus & Application form, write to programmes@igmpiindia.org mentioning the name of the Course.

Programme Highlights

P harma, Biotech, Food Processing, Medical Devices, Cosmetics, Homeopathy, Ayurveda, health supplements and alternate healthcare professionals, executives & students may complete these programmes from their own cities and whilst still being in service, business or education.

T he duration of Post Graduate Diploma is 12 months and Executive Diploma is 6 months.

T he Programme fee is Rs 10500/- for the Post Graduate Diploma as well as Executive Diploma. Eligiblity for admission in a PG Diploma Course is graduation. Final year students are also eligible. While for an Executive Diploma course, you need to have a minimum of 3 years of Industry experience.

T he Institute provides all the participants with free comprehensive study materials, assignments, case studies, webinar on select areas, LMS support & placement assistance.

I n recent months the Institute has witnessed more and more participation from professionals working with global pharmaceutical, healthcare and food giants like Dr. Reddy’s Laboratories, Aurobindo Pharma, Glenmark Generics, Cipla, Wockhardt, Pfizer, Abbott, Medtronic, Foster Corporation, Ipca Laboratories, Calyx, Mother Dairy, Bliss GVS Pharma, Al Rawabi, Almarai, Green Pastures, SeQuent, PepsiCo India, Mankind, Beryl Drugs, Allergy Therapeutics, CFTRI, Ciron, Sun Pharmaceutical, Novartis, GlaxoSmithKline, Biocon etc.

F or any query, counselling or free prospectus, you may call/write on +91 8130924488, +91 11 65353339 & programmes@igmpiindia.org , CCI Newswire

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

3 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

5 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago